167 related articles for article (PubMed ID: 3502682)
1. Bone turnover in spinal osteoporosis.
Pødenphant J; Johansen JS; Thomsen K; Riis BJ; Leth A; Christiansen C
J Bone Miner Res; 1987 Dec; 2(6):497-503. PubMed ID: 3502682
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
[TBL] [Abstract][Full Text] [Related]
3. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF
J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive evaluation of bone formation: measurements of serum alkaline phosphatase, whole body retention of diphosphonate and serum osteocalcin in metabolic bone disorders and thyroid disease.
Hyldstrup L; Clemmensen I; Jensen BA; Transbøl I
Scand J Clin Lab Invest; 1988 Nov; 48(7):611-9. PubMed ID: 3264412
[TBL] [Abstract][Full Text] [Related]
5. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
6. Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome.
Stĕpán JJ; Musilová J; Pacovský V
J Bone Miner Res; 1989 Apr; 4(2):193-8. PubMed ID: 2786321
[TBL] [Abstract][Full Text] [Related]
7. Biochemical picture of bone metabolism in breast cancer patients with bone metastases.
Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A
Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881
[TBL] [Abstract][Full Text] [Related]
8. Is heritability a risk factor for postmenopausal osteoporosis?
Hansen MA; Hassager C; Jensen SB; Christiansen C
J Bone Miner Res; 1992 Sep; 7(9):1037-43. PubMed ID: 1414496
[TBL] [Abstract][Full Text] [Related]
9. Biochemical effects of calcium supplementation in postmenopausal osteoporosis.
Horowitz M; Need AG; Morris HA; Wishart J; Nordin BE
Eur J Clin Nutr; 1988 Sep; 42(9):775-8. PubMed ID: 3181110
[TBL] [Abstract][Full Text] [Related]
10. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of serum osteocalcin and of the histomorphometric evaluation of iliac biopsy in postmenopausal osteoporosis].
Delmas PD; Brown JP; Malaval L; Edouard C; Chapuy MC; Meunier PJ
Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):581-4. PubMed ID: 6335924
[TBL] [Abstract][Full Text] [Related]
12. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
[TBL] [Abstract][Full Text] [Related]
13. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
Torres R; de la Piedra C; Rapado A
Scand J Clin Lab Invest; 1989 May; 49(3):279-85. PubMed ID: 2787049
[TBL] [Abstract][Full Text] [Related]
14. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women.
Horowitz M; Need AG; Philcox JC; Nordin BE
Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720
[TBL] [Abstract][Full Text] [Related]
15. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis.
Lumachi F; Ermani M; Camozzi V; Tombolan V; Luisetto G
Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E60-3. PubMed ID: 19751416
[TBL] [Abstract][Full Text] [Related]
16. Biochemical markers of bone turnover in rheumatoid arthritis. Relation to anti-inflammatory treatment, sex, and menopause.
Als OS; Riis BJ; Gotfredsen A; Christiansen C; Deftos LJ
Acta Med Scand; 1986; 219(2):209-13. PubMed ID: 3485890
[TBL] [Abstract][Full Text] [Related]
17. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
[TBL] [Abstract][Full Text] [Related]
18. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
Charles P; Poser JW; Mosekilde L; Jensen FT
J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
[TBL] [Abstract][Full Text] [Related]
19. Effect of etidronate disodium on bone turnover following surgical menopause.
Smith ML; Fogelman I; Hart DM; Scott E; Bevan J; Leggate I
Calcif Tissue Int; 1989 Feb; 44(2):74-9. PubMed ID: 2492893
[TBL] [Abstract][Full Text] [Related]
20. Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis.
Pietschmann P; Resch H; Krexner E; Woloszczuk W; Willvonseder R
Acta Med Austriaca; 1991; 18(5):114-6. PubMed ID: 1796722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
